Global drugs shares decrease on Monday after former President Donald Trump reducing the prices of medicines for American prescriptions to the levels seen in other high -income countries.
In a social publication of the truth, Trump undertakes to reduce drug prices by 59 %, after a previous pledge of 30 % to 80 % “almost immediately”.
American pharmaceutical shares including ABBIE, Amgen, Pfizer, Eli Lilly and Merck have decreased between 2.2 % and 3.7 % in pre -market trade. Pharmaceutical stocks in Europe, the United Kingdom, India, Australia and Japan decrease sharply.
In Europe, the Stoxx 600 health care index decreases by 2.9 %, with Astrazneca, GSK and ROCE between 3.3 % and 6.8 %. Indian companies Biocon and Lupine Slip where India sends about a third of its drug exports to the United States.
Australian health care shares have decreased by 1.4 % to their lowest level since April, with the CSL and Mayne Pharma group in particular due to exposure to American markets. In Japan, the pharmaceutical sector today ends with 6.5 %, with Daiichi Sankyo decreased over 8 %.
Hong Kong tumor lies with 14.4 % to $ 6.28, Hong Kong, which leads to losses between regional drug makers. Meanwhile, Washington and Beijing say they agree to reduce the similarly treated tariffs after weekends, a move aimed at sedative trade tensions that shook global markets.
